RhumbLine Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.6M | Sell |
|
|||||
|
2025
Q1 | $110M | Buy |
|
|||||
|
2024
Q4 | $122M | Sell |
|
|||||
|
2024
Q3 | $184M | Sell |
|
|||||
|
2024
Q2 | $189M | Sell |
|
|||||
|
2024
Q1 | $177M | Buy |
|
|||||
|
2023
Q4 | $159M | Sell |
|
|||||
|
2023
Q3 | $151M | Sell |
|
|||||
|
2023
Q2 | $134M | Buy |
|
|||||
|
2023
Q1 | $151M | Sell |
|
|||||
|
2022
Q4 | $136M | Buy |
|
|||||
|
2022
Q3 | $123M | Buy |
|
|||||
|
2022
Q2 | $103M | Buy |
|
|||||
|
2022
Q1 | $114M | Buy |
|
|||||
|
2021
Q4 | $102M | Buy |
|
|||||
|
2021
Q3 | $97.6M | Sell |
|
|||||
|
2021
Q2 | $90.4M | Sell |
|
|||||
|
2021
Q1 | $78.2M | Sell |
|
|||||
|
2020
Q4 | $84M | Sell |
|
|||||
|
2020
Q3 | $108M | Sell |
|
|||||
|
2020
Q2 | $122M | Buy |
|
|||||
|
2020
Q1 | $71.5M | Buy |
|
|||||
|
2019
Q4 | $54.8M | Buy |
|
|||||
|
2019
Q3 | $39.2M | Buy |
|
|||||
|
2019
Q2 | $42.3M | Buy |
|
|||||
|
2019
Q1 | $54.5M | Sell |
|
|||||
|
2018
Q4 | $55M | Buy |
|
|||||
|
2018
Q3 | $59M | Sell |
|
|||||
|
2018
Q2 | $50.9M | Buy |
|
|||||
|
2018
Q1 | $49.4M | Buy |
|
|||||
|
2017
Q4 | $53.8M | Buy |
|
|||||
|
2017
Q3 | $60.5M | Buy |
|
|||||
|
2017
Q2 | $65.4M | Buy |
|
|||||
|
2017
Q1 | $50.8M | Buy |
|
|||||
|
2016
Q4 | $47.1M | Buy |
|
|||||
|
2016
Q3 | $50.7M | Buy |
|
|||||
|
2016
Q2 | $42.9M | Buy |
|
|||||
|
2016
Q1 | $42.7M | Buy |
|
|||||
|
2015
Q4 | $62M | Buy |
|
|||||
|
2015
Q3 | $51.8M | Buy |
|
|||||
|
2015
Q2 | $54.9M | Sell |
|
|||||
|
2015
Q1 | $57.2M | Sell |
|
|||||
|
2014
Q4 | $52.6M | Sell |
|
|||||
|
2014
Q3 | $47.4M | Sell |
|
|||||
|
2014
Q2 | $38.6M | Sell |
|
|||||
|
2014
Q1 | $42.3M | Buy |
|
|||||
|
2013
Q4 | $38.5M | Sell |
|
|||||
|
2013
Q3 | $44.6M | Sell |
|
|||||
|
2013
Q2 | $32.6M | Buy |
|